Patents by Inventor Sheila Martinson Campbell

Sheila Martinson Campbell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5733579
    Abstract: An oral rehydration solution contains indigestible oligosaccharides. Diarrhea related dehydration requires fluid and electrolyte replacement. The primary etiology of antibiotic-associated diarrhea (also known as pseudomembranous colitis) has been recognized as Clostridium difficile. It is believed that the indigenous microflora of a healthy individual suppresses the normally present C. difficile. However, when the indigenous microflora are disrupted (e.g., during antibiotic treatment) overgrowth of C. difficile may occur causing diarrhea and colitis. Treatment of diarrhea related to C. difficile with rehydration therapy and antibiotics has proven effective, but many times relapse occurs. It has been suggested that normalization of the microflora will inhibit C. difficile relapse. Indigestible oligosaccharides have been shown to inhibit C. difficile infection.
    Type: Grant
    Filed: April 5, 1995
    Date of Patent: March 31, 1998
    Assignee: Abbott Laboratories
    Inventors: Bryan Warren Wolf, Keith Allen Garleb, Sheila Martinson Campbell, Jonathan Allan Meulbroek, Keith Brian Wheeler, Joseph Edward Walton